IonQ Inc (NYSE: IONQ): Stock That Needs Special Handling

Currently, there are 206.61M common shares owned by the public and among those 173.44M shares have been available to trade.

However, the script later moved the day high at 10.25, down -6.31%. The company’s stock has a 5-day price change of -1.99% and -24.46% over the past three months. IONQ shares are trading -24.46% year to date (YTD), with the 12-month market performance up to 84.25% higher. It has a 12-month low price of $5.29 and touched a high of $21.60 over the same period. IONQ has an average intraday trading volume of 7.04 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.63%, -10.05%, and -27.77% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of IonQ Inc (NYSE: IONQ) shares accounts for 37.55% of the company’s 206.61M shares outstanding.

It has a market capitalization of $1.95B and a beta (3y monthly) value of 2.13. The earnings-per-share (ttm) stands at -$0.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.37% over the week and 6.67% over the month.

Earnings per share for the fiscal year are expected to decrease by -35.58%, and -3.55% over the next financial year.

Looking at the support for the IONQ, a number of firms have released research notes about the stock. Craig Hallum stated their Buy rating for the stock in a research note on August 11, 2023, with the firm’s price target at $12-$21. Morgan Stanley coverage for the IonQ Inc (IONQ) stock in a research note released on April 26, 2023 offered a Equal-Weight rating with a price target of $7. Needham was of a view on June 08, 2022 that the stock is Buy, while Goldman gave the stock Neutral rating on November 22, 2021, issuing a price target of $28.

Most Popular

Related Posts